EUCTR2016-003594-17-NL进行中（未招募）1 期
Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bonefractures caused by acute Charcotfoot in patients with diabetes mellitus (CHARCOT study) - CHARCOT study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- AMC
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •diabetes with neuropathy
- •acute charcot foot
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Radiologically proven Charcot foot (x ray or MRI)
- •- Male/female gender
- •- Confirmed diagnosis of either type 1 or type 2 diabetes with neuropathy
研究者
相似试验
招募中
2 期
Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bonefractures caused by acute Charcotfoot in patients with diabetes mellitus (CHARCOT study)10012653charcot footdiabetesNL-OMON50445Academisch Medisch Centrum30
招募中
不适用
Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bonefractures caused by acute Charcotfoot in patients with diabetes mellitus (CHARCOT study)DMcharcot footdenosumabNL-OMON21814AMC30
终止
1 期
Effects of Denosumab on the Pharmacokinetics of EtanerceptPostmenopausalOsteopeniaOsteoporosisRheumatoid ArthritisNCT01294397Amgen19
招募中
不适用
Early administration of denosumab of distal radius fracture after volar plate fixatioDiseases of the musculoskeletal system and connective tissueKCT0004872Chung-Ang Univerisity Hospital48
已完成
2 期
The efficacy of the use of denosumab in the prevention of aromatase inhibitor-induced bone loss in postmenopausal women with hormone receptor-positive breast cancer who are currently on or will iniate an aromatase inhibitor in the adjuvant settingBreast CancerJPRN-UMIN000013863Department of Endocrine and breast cancer, Kyoto Prefectural University of medicine100